Cellectis SA (XPAR:ALCLS)
€ 1.48 -0.02 (-1.33%) Market Cap: 148.14 Mil Enterprise Value: -14.65 Mil PE Ratio: 0 PB Ratio: 1.29 GF Score: 44/100

Cellectis SA at Barclays Virtual Gene Editing & Gene Therapy Summit - Presentation Transcript

Nov 16, 2020 / 02:15PM GMT
Release Date Price: €16.64 (+4.39%)
Huidong Wang
Barclays Bank PLC, Research Division - Research Analyst

Presentation
Nov 16, 2020 / 02:15PM GMT

=====================
Corporate Participants
=====================
* André Choulika
Cellectis S.A. - Co-Founder, CEO & Director
* Carrie Brownstein
Cellectis S.A. - Chief Medical Officer
* Simon Harnest
Cellectis S.A. - SVP of Corporate Strategy & Finance

=====================
Conference Call Participants
=====================
* Huidong Wang
Barclays Bank PLC, Research Division - Research Analyst

=====================
-

AndrÃ;Choulika
Cellectis S.A. - Co-Founder, CEO & Director

Thank you, everyone. Welcome to our next speakers from Cellectis. Today with me, we have André Choulika, the Chief Executive Officer; Carrie Brownstein, Chief Medical Officer; and also Simon Harnest, SVP of Corporate Strategy and Finance.

With that, I hand over to André.

© -

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot